Clinical Trial for High Intensity Laser Therapy (HILT) for Elbow Epicondylosis
Unknown statusNot applicableNCT01992627
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will determine the efficacy of High Intensity Laser Therapy (HILT) for the treatment of elbow epicondylosis
Study details
- Official title
- A Prospective Randomized Clinical Trial of High Intensity Laser Therapy for Elbow Epicondylosis
- Conditions
- Chronic Pain
- Elbow Tenderness
- Elbow Pain Upon Active Resistive Motion
- Interventions
- Device: HILTERAPIA HIRO 3.0
- Sponsor
- CM Chungmu Hospital
- Start date
- 2013-10
- Primary completion
- 2013-12
- Sex
- All
- Age range
- from 35 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * history of medial and lateral elbow pain for at least three months in duration * local tenderness for at least three months in duration * pain on the epicondyle upon active resistive flexion (medial) and extension (lateral) of the wrist Exclusion Criteria: * previous elbow conservative managements such as physical therapy and elbow injection-based therapies * previous surgical management of the elbow
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01992627